<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     naa a22        4500</leader>
  <controlfield tag="001">510776167</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180411083231.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">180411e20131001xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s12975-013-0259-0</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s12975-013-0259-0</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Interaction Between vWF Levels and Aspirin Resistance in Ischemic Stroke Patients</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Yıldız Arslan, Tahir Yoldaş, Yaşar Zorlu]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The von Willebrand factor (vWF) levels increase in acute-phase ischemic stroke because of endothelial dysfunction and thrombus formation and may reduce acetylsalicylic acid (ASA) efficiency in hemostatic cascade. The aim of the study is to investigate the relationship between vWF levels and ASA resistance in ischemic stroke patients. Fifty acute ischemic stroke patients (mean age 66.3 ± 13years, 34 males) were given 300mg/day aspirin for at least 10days, and 25 healthy volunteers as a control group were compared using platelet function analyzer-100 test. All risk factors were investigated for a correlation to ASA resistance. ASA resistance was apparent in 32% of the study group and in 20% of the control group (p = 0.140). vWF levels were elevated in only ASA nonresponders and the ischemic stroke group that showed a statistically significant association with aspirin resistance (p ≤ 0.05). vWF levels increase in ASA nonresponders and ischemic stroke group in acute phase. High vWF levels may relate to ASA resistance and recurrent strokes.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer Science+Business Media New York, 2013</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">ASA resistance</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">vWF levels</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Ischemic stroke</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Arslan</subfield>
   <subfield code="D">Yıldız</subfield>
   <subfield code="u">Neurology Clinic, İzmir Tepecik Education and Research Hospital, Yenişehir Mah, 35120, Konak, Izmir, Turkey</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Yoldaş</subfield>
   <subfield code="D">Tahir</subfield>
   <subfield code="u">Neurology Clinic, Ankara Dişkapi Education and Research Hospital, Ankara, Turkey</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Zorlu</subfield>
   <subfield code="D">Yaşar</subfield>
   <subfield code="u">Neurology Clinic, İzmir Tepecik Education and Research Hospital, Yenişehir Mah, 35120, Konak, Izmir, Turkey</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Translational Stroke Research</subfield>
   <subfield code="d">Springer US; http://www.springer-ny.com</subfield>
   <subfield code="g">4/5(2013-10-01), 484-487</subfield>
   <subfield code="x">1868-4483</subfield>
   <subfield code="q">4:5&lt;484</subfield>
   <subfield code="1">2013</subfield>
   <subfield code="2">4</subfield>
   <subfield code="o">12975</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s12975-013-0259-0</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s12975-013-0259-0</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Arslan</subfield>
   <subfield code="D">Yıldız</subfield>
   <subfield code="u">Neurology Clinic, İzmir Tepecik Education and Research Hospital, Yenişehir Mah, 35120, Konak, Izmir, Turkey</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Yoldaş</subfield>
   <subfield code="D">Tahir</subfield>
   <subfield code="u">Neurology Clinic, Ankara Dişkapi Education and Research Hospital, Ankara, Turkey</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Zorlu</subfield>
   <subfield code="D">Yaşar</subfield>
   <subfield code="u">Neurology Clinic, İzmir Tepecik Education and Research Hospital, Yenişehir Mah, 35120, Konak, Izmir, Turkey</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Translational Stroke Research</subfield>
   <subfield code="d">Springer US; http://www.springer-ny.com</subfield>
   <subfield code="g">4/5(2013-10-01), 484-487</subfield>
   <subfield code="x">1868-4483</subfield>
   <subfield code="q">4:5&lt;484</subfield>
   <subfield code="1">2013</subfield>
   <subfield code="2">4</subfield>
   <subfield code="o">12975</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
